Reply To: Plume?

DeeAnn Hopings

Ah, found the information that I had previously posted…

This link from the Boston University School of Medicine includes the medication and monitoring regimes for F>M and M>F.

Monitoring for transgender women (MTF) on hormone therapy:

  1. Monitor for feminizing and adverse effects every 3 months for first year and then every 6– 12 months.
  2. Monitor serum testosterone and estradiol at follow-up visits with a practical target in the female range (testosterone 30 – 100 ng/dl; E2 <200 pg/ml).
  3. Monitor prolactin and triglycerides before start- ing hormones and at follow-up visits.
  4. Monitor potassium levels if the patient is taking spironolactone.
  5. BMD screening before starting hormones for patients at risk for osteoporosis. Otherwise, start screening at age 60 or earlier if sex hormone levels are consistently low.
  6. MTF patients should be screened for breast and prostate cancer appropriately.


1 user thanked author for this post.

©2022 Transgender Heaven | Privacy | Terms of Service | Contact Vanessa | Affiliate

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Transgender Heaven.

You have Successfully Subscribed!

Log in with your credentials


Forgot your details?

Create Account

If you don't see the captcha above please disable ad and tracking blockers and reload the page.